WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1999010003) ANDROGEN ACTIVITY ANTAGONISTS AS THERAPIES FOR ANOREXIA, ANOREXIA NERVOSA, AND DISORDERS CHARACTERIZED BY A PATHOLOGICALLY UNDERWEIGHT CONDITION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1999/010003    International Application No.:    PCT/US1998/017825
Publication Date: 04.03.1999 International Filing Date: 27.08.1998
Chapter 2 Demand Filed:    24.03.1999    
IPC:
A61K 38/17 (2006.01), A61K 38/44 (2006.01), A61K 48/00 (2006.01)
Applicants: JANUS PHARMACEUTICALS, INC. [US/US]; 35th floor 12 East 49th Street New York, NY 10017 (US)
Inventors: LEDERMAN, Seth; (US).
LANDRY, Donald, W.; (US)
Agent: HALEY, James, F., Jr.; Fish & Neave 1251 Avenue of the Americas New York, NY 10020 (US)
Priority Data:
08/919,301 28.08.1997 US
Title (EN) ANDROGEN ACTIVITY ANTAGONISTS AS THERAPIES FOR ANOREXIA, ANOREXIA NERVOSA, AND DISORDERS CHARACTERIZED BY A PATHOLOGICALLY UNDERWEIGHT CONDITION
(FR) ANTAGONISTES DE L'ACTIVITE ANDROGENE UTILISES POUR LE TRAITEMENT DE L'ANOREXIE, DE L'ANOREXIE MENTALE ET DE TROUBLES CARACTERISES PAR UNE INSUFFISANCE PONDERALE PATHOLOGIQUE
Abstract: front page image
(EN)The present invention relates to the treatment of conditions characterized by loss of appetite (anorexia) and/or pathological weight loss by administering a therapeutically effective amount of an agent that modulates androgen activity. The present invention further relates to the treatment and prevention of anorexia nervosa with such agents.
(FR)L'invention concerne le traitement de pathologies caractérisées par une perte d'appétit (anorexie) et/ou une perte de poids pathologique, par l'administration d'une quantité thérapeutiquement active d'un agent modulateur de l'activité androgène. L'invention concerne en outre le traitement et la prévention de l'anorexie mentale avec de tels agents.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, HR, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, UZ, VN, YU, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)